25 XP   0   0   10

Fulgent Genetics Inc
Buy, Hold or Sell?

Let's analyse Fulgent Genetics Inc together

PenkeI guess you are interested in Fulgent Genetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fulgent Genetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Fulgent Genetics Inc

I send you an email if I find something interesting about Fulgent Genetics Inc.

Quick analysis of Fulgent Genetics Inc (30 sec.)










What can you expect buying and holding a share of Fulgent Genetics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
14.7%

What is your share worth?

Current worth
$38.05
Expected worth in 1 year
$33.46
How sure are you?
52.9%

+ What do you gain per year?

Total Gains per Share
$-4.58
Return On Investment
-22.8%

For what price can you sell your share?

Current Price per Share
$20.11
Expected price per share
$0 - $22.23
How sure are you?
50%

1. Valuation of Fulgent Genetics Inc (5 min.)




Live pricePrice per Share (EOD)

$20.11

Intrinsic Value Per Share

$-89.75 - $-111.91

Total Value Per Share

$-51.70 - $-73.86

2. Growth of Fulgent Genetics Inc (5 min.)




Is Fulgent Genetics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1.2b-$61.9m-5.0%

How much money is Fulgent Genetics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$42m$35.6m-$77.7m-184.8%
Net Profit Margin-59.4%5.7%--

How much money comes from the company's main activities?

3. Financial Health of Fulgent Genetics Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#31 / 146

Most Revenue
#63 / 146

Most Profit
#129 / 146

What can you expect buying and holding a share of Fulgent Genetics Inc? (5 min.)

Welcome investor! Fulgent Genetics Inc's management wants to use your money to grow the business. In return you get a share of Fulgent Genetics Inc.

What can you expect buying and holding a share of Fulgent Genetics Inc?

First you should know what it really means to hold a share of Fulgent Genetics Inc. And how you can make/lose money.

Speculation

The Price per Share of Fulgent Genetics Inc is $20.11. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fulgent Genetics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fulgent Genetics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $38.05. Based on the TTM, the Book Value Change Per Share is $-1.15 per quarter. Based on the YOY, the Book Value Change Per Share is $1.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fulgent Genetics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-4.30-21.4%-1.41-7.0%1.145.7%1.125.6%0.643.2%
Usd Book Value Change Per Share-3.99-19.9%-1.15-5.7%1.326.6%1.819.0%1.125.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.1%
Usd Total Gains Per Share-3.99-19.9%-1.14-5.7%1.326.6%1.829.0%1.135.6%
Usd Price Per Share28.91-30.98-46.21-42.15-26.63-
Price to Earnings Ratio-1.68--14.18-50.46-1.50--48.12-
Price-to-Total Gains Ratio-7.24--307.15--5,096.79--1,072.92--531.04-
Price to Book Ratio0.76-0.75-1.10-2.79-2.97-
Price-to-Total Gains Ratio-7.24--307.15--5,096.79--1,072.92--531.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.11
Number of shares49
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.151.81
Usd Total Gains Per Share-1.141.82
Gains per Quarter (49 shares)-56.0888.98
Gains per Year (49 shares)-224.33355.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-225-2340356346
21-449-4580711702
31-674-682110671058
42-899-906114231414
52-1124-1130117781770
62-1348-1354121342126
73-1573-1578224902482
83-1798-1802228452838
93-2022-2026232013194
104-2247-2250235573550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%7.05.00.058.3%12.08.00.060.0%15.019.00.044.1%15.019.00.044.1%
Book Value Change Per Share0.04.00.00.0%6.06.00.050.0%12.08.00.060.0%18.014.02.052.9%18.014.02.052.9%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.018.010.0%5.00.029.014.7%5.00.029.014.7%
Total Gains per Share0.04.00.00.0%6.06.00.050.0%12.08.00.060.0%18.014.02.052.9%18.014.02.052.9%

Fundamentals of Fulgent Genetics Inc

About Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Fundamental data was last updated by Penke on 2024-04-11 07:59:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Fulgent Genetics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fulgent Genetics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fulgent Genetics Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -181.8% means that $-1.82 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fulgent Genetics Inc:

  • The MRQ is -181.8%. The company is making a huge loss. -2
  • The TTM is -59.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-181.8%TTM-59.4%-122.3%
TTM-59.4%YOY5.7%-65.2%
TTM-59.4%5Y3.2%-62.6%
5Y3.2%10Y-14.8%+18.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-181.8%-7.2%-174.6%
TTM-59.4%-6.3%-53.1%
YOY5.7%1.3%+4.4%
5Y3.2%-2.2%+5.4%
10Y-14.8%-1.4%-13.4%
1.1.2. Return on Assets

Shows how efficient Fulgent Genetics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fulgent Genetics Inc to the Diagnostics & Research industry mean.
  • -10.1% Return on Assets means that Fulgent Genetics Inc generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fulgent Genetics Inc:

  • The MRQ is -10.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.1%TTM-3.3%-6.8%
TTM-3.3%YOY2.4%-5.7%
TTM-3.3%5Y4.3%-7.5%
5Y4.3%10Y-3.0%+7.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.1%-1.5%-8.6%
TTM-3.3%-1.2%-2.1%
YOY2.4%-0.6%+3.0%
5Y4.3%-0.6%+4.9%
10Y-3.0%-0.9%-2.1%
1.1.3. Return on Equity

Shows how efficient Fulgent Genetics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fulgent Genetics Inc to the Diagnostics & Research industry mean.
  • -11.3% Return on Equity means Fulgent Genetics Inc generated $-0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fulgent Genetics Inc:

  • The MRQ is -11.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.3%TTM-3.6%-7.7%
TTM-3.6%YOY2.7%-6.3%
TTM-3.6%5Y5.3%-8.9%
5Y5.3%10Y-3.2%+8.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.3%-0.5%-10.8%
TTM-3.6%--3.6%
YOY2.7%0.3%+2.4%
5Y5.3%-1.5%+6.8%
10Y-3.2%-2.5%-0.7%

1.2. Operating Efficiency of Fulgent Genetics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fulgent Genetics Inc is operating .

  • Measures how much profit Fulgent Genetics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fulgent Genetics Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -43.8% means the company generated $-0.44  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fulgent Genetics Inc:

  • The MRQ is -43.8%. The company is operating very inefficient. -2
  • The TTM is -27.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-43.8%TTM-27.6%-16.2%
TTM-27.6%YOY6.1%-33.7%
TTM-27.6%5Y12.5%-40.1%
5Y12.5%10Y-6.1%+18.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-43.8%-6.2%-37.6%
TTM-27.6%-5.8%-21.8%
YOY6.1%4.8%+1.3%
5Y12.5%1.6%+10.9%
10Y-6.1%-2.0%-4.1%
1.2.2. Operating Ratio

Measures how efficient Fulgent Genetics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.44 means that the operating costs are $1.44 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fulgent Genetics Inc:

  • The MRQ is 1.438. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.276. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.438TTM1.276+0.162
TTM1.276YOY0.945+0.331
TTM1.2765Y0.855+0.420
5Y0.85510Y1.025-0.169
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4381.310+0.128
TTM1.2761.303-0.027
YOY0.9451.240-0.295
5Y0.8551.270-0.415
10Y1.0251.228-0.203

1.3. Liquidity of Fulgent Genetics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fulgent Genetics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 6.96 means the company has $6.96 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fulgent Genetics Inc:

  • The MRQ is 6.955. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.135. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.955TTM8.135-1.180
TTM8.135YOY7.356+0.780
TTM8.1355Y7.091+1.045
5Y7.09110Y8.536-1.446
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9552.194+4.761
TTM8.1352.366+5.769
YOY7.3562.753+4.603
5Y7.0912.989+4.102
10Y8.5363.000+5.536
1.3.2. Quick Ratio

Measures if Fulgent Genetics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fulgent Genetics Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 11.07 means the company can pay off $11.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fulgent Genetics Inc:

  • The MRQ is 11.070. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.907. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.070TTM13.907-2.837
TTM13.907YOY12.408+1.499
TTM13.9075Y11.889+2.018
5Y11.88910Y14.249-2.360
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0701.273+9.797
TTM13.9071.355+12.552
YOY12.4081.563+10.845
5Y11.8891.952+9.937
10Y14.2492.127+12.122

1.4. Solvency of Fulgent Genetics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fulgent Genetics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fulgent Genetics Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.11 means that Fulgent Genetics Inc assets are financed with 11.0% credit (debt) and the remaining percentage (100% - 11.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fulgent Genetics Inc:

  • The MRQ is 0.110. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.082. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.110TTM0.082+0.028
TTM0.082YOY0.095-0.013
TTM0.0825Y0.112-0.030
5Y0.11210Y0.099+0.013
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1100.425-0.315
TTM0.0820.411-0.329
YOY0.0950.393-0.298
5Y0.1120.450-0.338
10Y0.0990.448-0.349
1.4.2. Debt to Equity Ratio

Measures if Fulgent Genetics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fulgent Genetics Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 12.3% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fulgent Genetics Inc:

  • The MRQ is 0.123. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.089. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.123TTM0.089+0.034
TTM0.089YOY0.105-0.016
TTM0.0895Y0.129-0.040
5Y0.12910Y0.114+0.014
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1230.606-0.483
TTM0.0890.571-0.482
YOY0.1050.606-0.501
5Y0.1290.637-0.508
10Y0.1140.730-0.616

2. Market Valuation of Fulgent Genetics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fulgent Genetics Inc generates.

  • Above 15 is considered overpriced but always compare Fulgent Genetics Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -1.68 means the investor is paying $-1.68 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fulgent Genetics Inc:

  • The EOD is -1.169. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.680. Based on the earnings, the company is expensive. -2
  • The TTM is -14.180. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.169MRQ-1.680+0.511
MRQ-1.680TTM-14.180+12.500
TTM-14.180YOY50.460-64.640
TTM-14.1805Y1.503-15.683
5Y1.50310Y-48.125+49.628
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.169-0.202-0.967
MRQ-1.680-0.402-1.278
TTM-14.180-0.119-14.061
YOY50.460-0.003+50.463
5Y1.5032.211-0.708
10Y-48.1254.907-53.032
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fulgent Genetics Inc:

  • The EOD is 12.661. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 18.202. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -20.528. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.661MRQ18.202-5.540
MRQ18.202TTM-20.528+38.729
TTM-20.528YOY20.448-40.976
TTM-20.5285Y10.893-31.421
5Y10.89310Y-12.725+23.618
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD12.661-0.179+12.840
MRQ18.202-0.417+18.619
TTM-20.528-1.288-19.240
YOY20.448-2.547+22.995
5Y10.893-1.999+12.892
10Y-12.725-2.372-10.353
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fulgent Genetics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.76 means the investor is paying $0.76 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fulgent Genetics Inc:

  • The EOD is 0.529. Based on the equity, the company is cheap. +2
  • The MRQ is 0.760. Based on the equity, the company is cheap. +2
  • The TTM is 0.751. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.529MRQ0.760-0.231
MRQ0.760TTM0.751+0.009
TTM0.751YOY1.100-0.349
TTM0.7515Y2.792-2.042
5Y2.79210Y2.971-0.179
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.5291.877-1.348
MRQ0.7602.437-1.677
TTM0.7512.235-1.484
YOY1.1003.239-2.139
5Y2.7923.450-0.658
10Y2.9714.040-1.069
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Fulgent Genetics Inc.

3.1. Institutions holding Fulgent Genetics Inc

Institutions are holding 49.361% of the shares of Fulgent Genetics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc12.58130.002837618781563074.3352
2023-12-31Dimensional Fund Advisors, Inc.4.83990.0122144715314750511.3496
2023-12-31Vanguard Group Inc4.73630.00091416191224801.613
2023-12-31State Street Corporation2.71880.0011812932408565.2917
2023-12-31Geode Capital Management, LLC1.54770.0014462760200704.5336
2023-12-31Park West Asset Management LLC1.42061.20314247837964923.0777
2023-12-31Amvescap Plc.1.23550.00253694135678618.1641
2023-12-31Millennium Management LLC1.21980.00463647283332991060.4824
2023-12-31JPMorgan Chase & Co1.12170.00093354034566115.7592
2023-12-31Nuveen Asset Management, LLC0.92240.002627580795263.5774
2023-12-31Charles Schwab Investment Management Inc0.8940.0022673133314114.1524
2023-12-31Morgan Stanley - Brokerage Accounts0.88050.0007263286129295.1642
2023-12-31Ameriprise Financial Inc0.83820.0022250621184263277.6802
2023-12-31Northern Trust Corp0.77390.001223139675883.3904
2023-12-31Goldman Sachs Group Inc0.6850.000520482410112297.5121
2023-09-30Citadel Advisors Llc0.64550.0011193016-271406-58.4395
2023-12-31NORGES BANK0.59030.0009176510104623145.5381
2023-12-31Bank of New York Mellon Corp0.52150.0009155929-57817-27.0494
2023-12-31Bridgeway Capital Management, LLC0.51390.0953153650-40976-21.0537
2023-12-31Divisadero Street Capital Management, LP0.45920.897137311-722689-84.0336
Total 39.1462.233911704904+262917+2.2%

3.2. Funds holding Fulgent Genetics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28iShares Core S&P Small-Cap ETF4.56590.0369136522919520.1432
2024-02-29Vanguard Total Stock Mkt Idx Inv2.0190.000960370300
2024-03-28iShares Russell 2000 ETF1.68860.01675049092430.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.99150.0066296459-419-0.1411
2024-02-29DFA US Small Cap Value I0.96610.0424288865-56271-16.304
2024-03-28iShares S&P Small-Cap 600 Value ETF0.83470.075249569-230-0.0921
2024-02-29DFA US Targeted Value I0.70990.0371212254-1062-0.4979
2024-01-31Fidelity Small Cap Index0.68750.020420556027041.333
2024-03-28iShares Russell 2000 Value ETF0.62260.0322186174-118-0.0633
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.60280.03721802461850.1027
2024-02-29BlackRock Global Equity Mkt Netrl Instl0.54880.28331641054361336.1958
2024-03-29Dimensional US Targeted Value ETF0.5340.034515966500
2024-02-29Vanguard Tax-Managed Small Cap Adm0.52650.0415742300
2024-03-28iShares Biotechnology ETF0.48910.041614625000
2024-03-28SPDR® S&P 600 Small Cap Value ETF0.47350.07714156800
2024-02-29DFA US Small Cap I0.42150.01831260326083693.3125
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.41440.006712390822001.8076
2023-12-31Columbia Small Cap Value I0.41360.261912368014001.1449
2024-02-29Columbia Small Cap Value I A0.41330.2095123580-900-0.723
2024-02-29Fidelity Extended Market Index0.40080.007111983076206.7908
Total 18.32411.28535479009+61753+1.1%

3.3. Insider Transactions

Insiders are holding 31.768% of the shares of Fulgent Genetics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-11Jian XieSELL2200026.52
2023-12-04Jian XieSELL177927.57
2023-12-04Paul KimSELL143727.57
2023-11-16Jian XieSELL161727.25
2023-11-16Paul KimSELL130727.25
2023-09-07Hanlin GaoSELL104131.41
2023-09-07Jian XieSELL149231.41
2023-08-28Paul KimSELL1029933.62
2023-08-17Hanlin GaoSELL34233.88
2023-08-17Jian XieSELL130733.88
2023-08-17Paul KimSELL179833.88
2023-06-02Hanlin GaoSELL100040.3
2023-06-02Jian XieSELL143340.3
2023-06-02Paul KimSELL140340.3

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Fulgent Genetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.994-1.146-71%1.317-403%1.815-320%1.119-457%
Book Value Per Share--38.04941.267-8%42.051-10%24.956+52%15.208+150%
Current Ratio--6.9558.135-15%7.356-5%7.091-2%8.536-19%
Debt To Asset Ratio--0.1100.082+35%0.095+16%0.112-2%0.099+11%
Debt To Equity Ratio--0.1230.089+38%0.105+17%0.129-5%0.114+7%
Dividend Per Share---0.002-100%-0%0.001-100%0.014-100%
Eps---4.302-1.408-67%1.139-478%1.125-483%0.640-772%
Free Cash Flow Per Share--0.3970.040+894%1.895-79%1.467-73%0.855-54%
Free Cash Flow To Equity Per Share---0.474-0.361-24%1.263-138%1.886-125%1.188-140%
Gross Profit Margin--1.0821.612-33%-0.977+190%0.756+43%1.943-44%
Intrinsic Value_10Y_max---111.909--------
Intrinsic Value_10Y_min---89.748--------
Intrinsic Value_1Y_max--5.714--------
Intrinsic Value_1Y_min--5.622--------
Intrinsic Value_3Y_max--4.267--------
Intrinsic Value_3Y_min--4.334--------
Intrinsic Value_5Y_max---12.734--------
Intrinsic Value_5Y_min---10.709--------
Market Cap598972328.000-44%861078568.000924370758.500-7%1428516488.500-40%1289081535.200-33%813043486.824+6%
Net Profit Margin---1.818-0.594-67%0.057-3262%0.032-5824%-0.148-92%
Operating Margin---0.438-0.276-37%0.061-819%0.125-449%-0.061-86%
Operating Ratio--1.4381.276+13%0.945+52%0.855+68%1.025+40%
Pb Ratio0.529-44%0.7600.751+1%1.100-31%2.792-73%2.971-74%
Pe Ratio-1.169+30%-1.680-14.180+744%50.460-103%1.503-212%-48.125+2765%
Price Per Share20.110-44%28.91030.975-7%46.210-37%42.148-31%26.631+9%
Price To Free Cash Flow Ratio12.661-44%18.202-20.528+213%20.448-11%10.893+67%-12.725+170%
Price To Total Gains Ratio-5.035+30%-7.239-307.147+4143%-5096.791+70310%-1072.915+14722%-531.036+7236%
Quick Ratio--11.07013.907-20%12.408-11%11.889-7%14.249-22%
Return On Assets---0.101-0.033-68%0.024-517%0.043-335%-0.030-70%
Return On Equity---0.113-0.036-68%0.027-517%0.053-314%-0.032-71%
Total Gains Per Share---3.994-1.145-71%1.317-403%1.816-320%1.133-452%
Usd Book Value--1133286000.0001231841250.000-8%1293741250.000-12%759905850.000+49%462725529.412+145%
Usd Book Value Change Per Share---3.994-1.146-71%1.317-403%1.815-320%1.119-457%
Usd Book Value Per Share--38.04941.267-8%42.051-10%24.956+52%15.208+150%
Usd Dividend Per Share---0.002-100%-0%0.001-100%0.014-100%
Usd Eps---4.302-1.408-67%1.139-478%1.125-483%0.640-772%
Usd Free Cash Flow--11827000.0001199000.000+886%58686250.000-80%45218450.000-74%26343823.529-55%
Usd Free Cash Flow Per Share--0.3970.040+894%1.895-79%1.467-73%0.855-54%
Usd Free Cash Flow To Equity Per Share---0.474-0.361-24%1.263-138%1.886-125%1.188-140%
Usd Market Cap598972328.000-44%861078568.000924370758.500-7%1428516488.500-40%1289081535.200-33%813043486.824+6%
Usd Price Per Share20.110-44%28.91030.975-7%46.210-37%42.148-31%26.631+9%
Usd Profit---128149000.000-42083500.000-67%35695750.000-459%34785600.000-468%19856147.059-745%
Usd Revenue--70505000.00072303250.000-2%154742000.000-54%117750250.000-40%71152176.471-1%
Usd Total Gains Per Share---3.994-1.145-71%1.317-403%1.816-320%1.133-452%
 EOD+4 -4MRQTTM+5 -31YOY+6 -285Y+10 -2610Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Fulgent Genetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.169
Price to Book Ratio (EOD)Between0-10.529
Net Profit Margin (MRQ)Greater than0-1.818
Operating Margin (MRQ)Greater than0-0.438
Quick Ratio (MRQ)Greater than111.070
Current Ratio (MRQ)Greater than16.955
Debt to Asset Ratio (MRQ)Less than10.110
Debt to Equity Ratio (MRQ)Less than10.123
Return on Equity (MRQ)Greater than0.15-0.113
Return on Assets (MRQ)Greater than0.05-0.101
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Fulgent Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.279
Ma 20Greater thanMa 5021.253
Ma 50Greater thanMa 10022.828
Ma 100Greater thanMa 20025.112
OpenGreater thanClose20.000
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -20,9033,707-17,196-3,550-20,7463,855-16,89118,0961,205
Total Other Income Expense Net 3,1166593,7751,3235,0981,5486,646-120,955-114,309



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,273,109
Total Liabilities139,823
Total Stockholder Equity1,136,101
 As reported
Total Liabilities 139,823
Total Stockholder Equity+ 1,136,101
Total Assets = 1,273,109

Assets

Total Assets1,273,109
Total Current Assets507,845
Long-term Assets765,264
Total Current Assets
Cash And Cash Equivalents 97,473
Short-term Investments 326,681
Net Receivables 57,445
Other Current Assets 26,246
Total Current Assets  (as reported)507,845
Total Current Assets  (calculated)507,845
+/-0
Long-term Assets
Property Plant Equipment 94,302
Goodwill 22,055
Long Term Investments 444,009
Intangible Assets 143,053
Long-term Assets Other 32,026
Long-term Assets  (as reported)765,264
Long-term Assets  (calculated)735,445
+/- 29,819

Liabilities & Shareholders' Equity

Total Current Liabilities73,018
Long-term Liabilities66,805
Total Stockholder Equity1,136,101
Total Current Liabilities
Short-term Debt 5,684
Short Long Term Debt 1,183
Accounts payable 15,360
Other Current Liabilities 49,100
Total Current Liabilities  (as reported)73,018
Total Current Liabilities  (calculated)71,327
+/- 1,691
Long-term Liabilities
Long term Debt 2,964
Capital Lease Obligations 11,104
Long-term Liabilities Other 10,951
Long-term Liabilities  (as reported)66,805
Long-term Liabilities  (calculated)25,019
+/- 41,786
Total Stockholder Equity
Common Stock3
Retained Earnings 633,175
Accumulated Other Comprehensive Income 1,205
Other Stockholders Equity 501,718
Total Stockholder Equity (as reported)1,136,101
Total Stockholder Equity (calculated)1,136,101
+/-0
Other
Capital Stock3
Cash and Short Term Investments 424,154
Common Stock Shares Outstanding 29,771
Current Deferred Revenue2,874
Liabilities and Stockholders Equity 1,273,109
Net Debt -82,566
Net Invested Capital 1,140,248
Net Working Capital 434,827
Property Plant and Equipment Gross 135,097
Short Long Term Debt Total 14,907



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
> Total Assets 
0
5,832
0
26,778
22,672
58,040
58,820
58,805
58,670
56,951
55,514
55,548
54,846
55,015
55,652
56,436
61,145
88,756
89,325
95,915
247,311
700,461
999,083
1,049,855
1,204,668
1,278,720
1,465,590
1,461,662
1,405,782
1,386,053
1,376,767
1,354,577
1,358,398
1,273,109
1,273,1091,358,3981,354,5771,376,7671,386,0531,405,7821,461,6621,465,5901,278,7201,204,6681,049,855999,083700,461247,31195,91589,32588,75661,14556,43655,65255,01554,84655,54855,51456,95158,67058,80558,82058,04022,67226,77805,8320
   > Total Current Assets 
0
2,930
0
21,801
12,611
50,829
33,170
50,302
47,502
45,372
43,739
43,118
42,930
43,374
42,973
44,225
48,897
76,771
76,995
16,294
194,650
615,726
659,140
925,615
622,836
1,074,458
1,238,557
675,185
1,022,165
905,632
914,867
528,289
549,855
507,845
507,845549,855528,289914,867905,6321,022,165675,1851,238,5571,074,458622,836925,615659,140615,726194,65016,29476,99576,77148,89744,22542,97343,37442,93043,11843,73945,37247,50250,30233,17050,82912,61121,80102,9300
       Cash And Cash Equivalents 
0
489
0
16,060
8,205
7,897
6,734
11,473
9,478
6,490
5,274
3,654
8,489
6,736
5,288
9,165
20,522
11,965
9,302
2,431
53,031
87,426
151,461
100,461
214,877
164,894
353,069
138,780
168,770
79,506
66,172
58,348
84,076
97,473
97,47384,07658,34866,17279,506168,770138,780353,069164,894214,877100,461151,46187,42653,0312,4319,30211,96520,5229,1655,2886,7368,4893,6545,2746,4909,47811,4736,7347,8978,20516,06004890
       Short-term Investments 
0
0
0
0
0
38,568
20,633
34,643
34,430
34,877
33,496
34,409
28,364
30,684
33,122
29,517
23,083
58,251
61,322
18,530
50,939
344,443
258,317
676,578
255,102
770,652
725,227
376,622
749,236
773,377
805,146
400,083
383,726
326,681
326,681383,726400,083805,146773,377749,236376,622725,227770,652255,102676,578258,317344,44350,93918,53061,32258,25123,08329,51733,12230,68428,36434,40933,49634,87734,43034,64320,63338,56800000
       Net Receivables 
0
2,155
0
2,793
4,406
4,364
4,847
4,186
3,594
4,005
4,969
5,055
6,077
5,954
4,563
5,543
5,292
6,555
6,371
13,863
90,680
183,857
219,149
148,576
125,559
138,912
160,261
137,502
104,159
52,749
43,549
39,683
54,628
57,445
57,44554,62839,68343,54952,749104,159137,502160,261138,912125,559148,576219,149183,85790,68013,8636,3716,5555,2925,5434,5635,9546,0775,0554,9694,0053,5944,1864,8474,3644,4062,79302,1550
       Other Current Assets 
0
212
0
10
525
322
493
279
260
2,438
398
407
301
314
423
405
244
277
1,257
3,525
2,069
3,696
4,529
4,311
5,348
5,960
4,696
10,339
10,454
22,248
32,689
35,049
32,776
26,246
26,24632,77635,04932,68922,24810,45410,3394,6965,9605,3484,3114,5293,6962,0693,5251,2572772444054233143014073982,4382602794933225251002120
   > Long-term Assets 
0
2,902
0
4,977
10,061
7,211
25,650
8,503
11,168
11,579
11,775
12,430
11,916
11,641
12,679
12,211
12,248
11,985
12,330
79,621
52,661
84,735
339,943
124,240
581,832
204,262
227,033
786,477
383,617
480,421
461,900
826,288
808,543
765,264
765,264808,543826,288461,900480,421383,617786,477227,033204,262581,832124,240339,94384,73552,66179,62112,33011,98512,24812,21112,67911,64111,91612,43011,77511,57911,1688,50325,6507,21110,0614,97702,9020
       Property Plant Equipment 
0
2,469
0
4,977
5,178
6,234
5,894
6,737
6,490
7,272
6,853
7,325
6,853
6,446
6,046
5,937
6,396
5,974
5,698
6,013
17,385
40,199
46,987
51,086
60,166
62,287
68,622
86,049
81,807
81,353
79,083
87,556
85,265
94,302
94,30285,26587,55679,08381,35381,80786,04968,62262,28760,16651,08646,98740,19917,3856,0135,6985,9746,3965,9376,0466,4466,8537,3256,8537,2726,4906,7375,8946,2345,1784,97702,4690
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,107
48,749
50,897
50,999
121,354
120,313
143,027
143,120
141,970
141,844
22,055
22,055141,844141,970143,120143,027120,313121,35450,99950,89748,74923,10700000000000000000000000
       Long Term Investments 
0
0
0
0
0
25,597
19,643
17,243
20,044
16,820
11,977
9,416
5,996
7,898
10,216
12,781
12,396
42,819
43,917
45,833
30,656
132,502
287,626
393,250
407,284
507,012
493,182
415,621
346,946
339,033
366,833
388,383
398,817
444,009
444,009398,817388,383366,833339,033346,946415,621493,182507,012407,284393,250287,626132,50230,65645,83343,91742,81912,39612,78110,2167,8985,9969,41611,97716,82020,04417,24319,64325,59700000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,829
36,684
35,914
35,037
89,695
87,853
150,643
148,699
146,473
144,489
143,053
143,053144,489146,473148,699150,64387,85389,69535,03735,91436,6846,82900000000000000000000000
       Other Assets 
0
433
0
0
86
25,668
19,756
17,341
20,142
16,985
535
612
947
17
231
167
409
251
160
80
975
44,536
38,183
6,721
8,949
266,549
26,497
61,777
41,643
26,556
0
33,424
0
0
0033,424026,55641,64361,77726,497266,5498,9496,72138,18344,536975801602514091672311794761253516,98520,14217,34119,75625,66886004330
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
126
505
592
929
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000929592505126000000000
> Total Liabilities 
0
686
0
5,075
5,431
3,561
3,524
3,072
3,399
2,925
2,415
2,987
2,266
2,745
5,691
5,294
6,619
5,979
7,953
8,872
60,356
131,074
197,517
129,130
160,215
112,840
152,630
150,929
124,385
116,178
107,848
91,251
96,564
139,823
139,82396,56491,251107,848116,178124,385150,929152,630112,840160,215129,130197,517131,07460,3568,8727,9535,9796,6195,2945,6912,7452,2662,9872,4152,9253,3993,0723,5243,5615,4315,07506860
   > Total Current Liabilities 
0
686
0
5,075
5,431
3,561
3,281
3,072
3,399
2,925
2,415
2,987
2,266
2,745
5,691
5,294
6,619
5,979
7,953
8,872
60,356
131,074
196,530
129,130
147,158
112,840
152,630
127,527
124,385
116,178
107,848
64,819
61,421
73,018
73,01861,42164,819107,848116,178124,385127,527152,630112,840147,158129,130196,530131,07460,3568,8727,9535,9796,6195,2945,6912,7452,2662,9872,4152,9253,3993,0723,2813,5615,4315,07506860
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
393
401
409
420
431
501
512
15,286
15,048
16,078
16,953
21,284
21,085
20,792
20,480
20,638
20,607
4,560
2,890
5,684
5,6842,8904,56020,60720,63820,48020,79221,08521,28416,95316,07815,04815,28651250143142040940139300000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
393
0
0
0
0
0
0
15,019
15,048
15,077
15,107
21,284
21,085
20,792
20,480
20,638
20,607
4,560
2,890
1,183
1,1832,8904,56020,60720,63820,48020,79221,08521,28415,10715,07715,04815,01900000039300000000000000
       Accounts payable 
0
314
0
4,633
3,286
2,756
2,306
1,820
2,370
2,089
1,347
1,794
1,024
1,313
1,456
1,175
2,150
1,581
2,855
3,636
18,674
26,488
17,440
14,743
24,868
20,494
23,699
37,109
14,481
23,093
22,080
20,607
15,772
15,360
15,36015,77220,60722,08023,09314,48137,10923,69920,49424,86814,74317,44026,48818,6743,6362,8551,5812,1501,1751,4561,3131,0241,7941,3472,0892,3701,8202,3062,7563,2864,63303140
       Other Current Liabilities 
0
372
0
442
2,145
805
975
1,252
1,029
836
1,068
1,193
1,242
1,432
1,354
1,333
1,634
3,613
4,223
4,113
22,714
62,724
133,081
46,067
55,948
36,686
76,015
30,565
61,011
58,353
50,807
22,591
21,312
49,100
49,10021,31222,59150,80758,35361,01130,56576,01536,68655,94846,067133,08162,72422,7144,1134,2233,6131,6341,3331,3541,4321,2421,1931,0688361,0291,2529758052,14544203720
   > Long-term Liabilities 
0
0
0
0
503
245
243
245
248
6
6
9
11
14
2,488
2,385
2,366
2,256
2,143
2,363
2,620
959
987
7,606
13,057
7,530
10,916
23,402
21,863
28,071
25,909
26,432
35,143
66,805
66,80535,14326,43225,90928,07121,86323,40210,9167,53013,0577,6069879592,6202,3632,1432,2562,3662,3852,48814119662482452432455030000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,899
5,947
0
0
0
0
0
0
0
0
0
0000000005,9475,89900000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
126
505
592
929
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000929592505126000000000
       Other Liabilities 
0
0
0
0
0
2
243
2
5
6
6
9
11
14
0
0
0
0
0
0
389
391
488
519
7,110
788
4,645
23,402
9,531
17,458
15,239
17,023
0
0
0017,02315,23917,4589,53123,4024,6457887,110519488391389000000141196652243200000
       Deferred Long Term Liability 
0
0
0
0
503
243
243
243
243
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000002432432432435030000
> Total Stockholder Equity
0
5,146
0
21,703
17,241
54,479
55,296
55,733
55,271
54,026
53,099
52,561
52,580
52,270
49,961
51,142
54,526
82,777
81,372
87,043
186,955
569,387
801,566
920,725
1,036,780
1,165,880
1,312,960
1,304,765
1,281,397
1,269,875
1,268,919
1,259,763
1,258,698
1,136,101
1,136,1011,258,6981,259,7631,268,9191,269,8751,281,3971,304,7651,312,9601,165,8801,036,780920,725801,566569,387186,95587,04381,37282,77754,52651,14249,96152,27052,58052,56153,09954,02655,27155,73355,29654,47917,24121,70305,1460
   Common Stock
0
12,316
0
10,494
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
33333333333332222222222222222110,494012,3160
   Retained Earnings Total Equity
0
0
0
0
-55,967
-55,154
-54,922
-54,947
-56,040
-57,664
-59,321
-60,370
-60,965
-63,018
-64,926
-64,595
-63,133
-63,429
-65,385
-62,064
-15,426
150,881
350,924
430,736
553,258
657,597
811,576
823,113
824,832
0
785,660
774,431
0
0
00774,431785,6600824,832823,113811,576657,597553,258430,736350,924150,881-15,426-62,064-65,385-63,429-63,133-64,595-64,926-63,018-60,965-60,370-59,321-57,664-56,040-54,947-54,922-55,154-55,9670000
   Accumulated Other Comprehensive Income 
0
-900
0
-1,347
-1,628
-103
-85
-68
10
-44
-87
-82
-57
-35
95
203
179
146
-193
1,049
607
438
-216
-265
-212
-759
-12,493
-22,417
-25,602
-20,903
-17,196
-20,746
-16,891
1,205
1,205-16,891-20,746-17,196-20,903-25,602-22,417-12,493-759-212-265-2164386071,049-19314617920395-35-57-82-87-4410-68-85-103-1,628-1,3470-9000
   Capital Surplus 
0
0
0
0
73,211
109,734
110,301
110,746
111,299
111,884
112,431
113,011
113,600
114,203
114,790
115,532
117,478
146,058
146,948
148,056
201,772
418,065
450,855
482,255
483,731
501,908
507,046
504,066
477,814
0
495,981
506,075
0
0
00506,075495,9810477,814504,066507,046501,908483,731482,255450,855418,065201,772148,056146,948146,058117,478115,532114,790114,203113,600113,011112,431111,884111,299110,746110,301109,73473,2110000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
0
900
0
1,347
74,839
109,734
110,301
110,746
111,299
111,884
112,431
113,011
113,600
114,203
114,790
115,532
117,478
146,058
146,948
148,056
201,772
418,065
450,855
482,255
463,731
501,908
496,265
492,085
470,931
489,775
487,470
493,233
499,104
501,718
501,718499,104493,233487,470489,775470,931492,085496,265501,908463,731482,255450,855418,065201,772148,056146,948146,058117,478115,532114,790114,203113,600113,011112,431111,884111,299110,746110,301109,73474,8391,34709000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue289,213
Cost of Revenue-192,602
Gross Profit96,61196,611
 
Operating Income (+$)
Gross Profit96,611
Operating Expense-171,906
Operating Income-75,295-75,295
 
Operating Expense (+$)
Research Development41,440
Selling General Administrative88,999
Selling And Marketing Expenses41,467
Operating Expense171,906171,906
 
Net Interest Income (+$)
Interest Income18,609
Interest Expense-37,000
Other Finance Cost-37,000
Net Interest Income18,609
 
Pretax Income (+$)
Operating Income-75,295
Net Interest Income18,609
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-174,08523,495
EBIT - interestExpense = -112,295
-166,671
-130,825
Interest Expense37,000
Earnings Before Interest and Taxes (EBIT)-75,295-137,085
Earnings Before Interest and Taxes (EBITDA)-43,538
 
After tax Income (+$)
Income Before Tax-174,085
Tax Provision-2,630
Net Income From Continuing Ops-64,981-176,715
Net Income-167,825
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses364,508
Total Other Income/Expenses Net-98,790-18,609
 

Technical Analysis of Fulgent Genetics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fulgent Genetics Inc. The general trend of Fulgent Genetics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fulgent Genetics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fulgent Genetics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 20.69 < 21.89 < 22.23.

The bearish price targets are: .

Tweet this
Fulgent Genetics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fulgent Genetics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fulgent Genetics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fulgent Genetics Inc. The current macd is -0.67844876.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fulgent Genetics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Fulgent Genetics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Fulgent Genetics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Fulgent Genetics Inc Daily Moving Average Convergence/Divergence (MACD) ChartFulgent Genetics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fulgent Genetics Inc. The current adx is 28.52.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Fulgent Genetics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Fulgent Genetics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fulgent Genetics Inc. The current sar is 21.47.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Fulgent Genetics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fulgent Genetics Inc. The current rsi is 30.28. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Fulgent Genetics Inc Daily Relative Strength Index (RSI) ChartFulgent Genetics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fulgent Genetics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fulgent Genetics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Fulgent Genetics Inc Daily Stochastic Oscillator ChartFulgent Genetics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fulgent Genetics Inc. The current cci is -174.34582698.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Fulgent Genetics Inc Daily Commodity Channel Index (CCI) ChartFulgent Genetics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fulgent Genetics Inc. The current cmo is -49.67789966.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Fulgent Genetics Inc Daily Chande Momentum Oscillator (CMO) ChartFulgent Genetics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fulgent Genetics Inc. The current willr is -88.55721393.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Fulgent Genetics Inc Daily Williams %R ChartFulgent Genetics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Fulgent Genetics Inc.

Fulgent Genetics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fulgent Genetics Inc. The current atr is 0.64388863.

Fulgent Genetics Inc Daily Average True Range (ATR) ChartFulgent Genetics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fulgent Genetics Inc. The current obv is -6,669,305.

Fulgent Genetics Inc Daily On-Balance Volume (OBV) ChartFulgent Genetics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fulgent Genetics Inc. The current mfi is 17.52.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Fulgent Genetics Inc Daily Money Flow Index (MFI) ChartFulgent Genetics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fulgent Genetics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Fulgent Genetics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fulgent Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.279
Ma 20Greater thanMa 5021.253
Ma 50Greater thanMa 10022.828
Ma 100Greater thanMa 20025.112
OpenGreater thanClose20.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Fulgent Genetics Inc with someone you think should read this too:
  • Are you bullish or bearish on Fulgent Genetics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fulgent Genetics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fulgent Genetics Inc

I send you an email if I find something interesting about Fulgent Genetics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Fulgent Genetics Inc.

Receive notifications about Fulgent Genetics Inc in your mailbox!